Zeng et al70 showed that 1‐methyl‐4‐phenylpyridinium (MPP+) can trigger GSDMD‐mediated pyroptosis by NLRP3/caspase‐1 pathway in an in vitro PD model, suggesting that pyroptosis acts as an inflammatory contributor in PD progression. This evidence concerns the gene GSDMD and Parkinson disease.